Item | Treatment1 | SEM | P-values | |||||
---|---|---|---|---|---|---|---|---|
CON | MR | SF | MRS | Treatment | Period | Treatment x Period | ||
Insulin-like growth factor-I (ng/mL) | ||||||||
Period 3—28 days | 43.9 | 44.1 | 38.8 | 42.4 | 2.65 | 0.25 | < 0.001 | 0.45 |
Period 29—56 days | 37.7b | 53.4a | 39.2b | 39.3b | 2.21 | 0.028 | < 0.001 | 0.56 |
Overall 3—56 days | 41.4b | 51.0a | 38.4b | 41.2b | 2.88 | 0.022 | < 0.001 | 0.59 |
β-hydroxybutyrate (mmol/L) | ||||||||
Period 3—28 days | 0.40 | 0.39 | 0.39 | 0.40 | 0.01 | 0.25 | < 0.001 | 0.22 |
Period 29—56 days | 0.51b | 0.62a | 0.50b | 0.53b | 0.01 | 0.033 | < 0.001 | 0.23 |
Overall 3—56 days | 0.45b | 0.53a | 0.45b | 0.45b | 0.01 | 0.028 | < 0.001 | 0.25 |
Non-esterified fatty acids (mmol/L) | ||||||||
Period 3—28 days | 0.28 | 0.35 | 0.36 | 0.31 | 0.01 | 0.59 | < 0.001 | 0.82 |
Period 29—56 days | 0.30 | 0.31 | 0.38 | 0.30 | 0.01 | 0.60 | < 0.001 | 0.62 |
Overall 3—56 days | 0.29 | 0.33 | 0.37 | 0.31 | 0.01 | 0.59 | < 0.001 | 0.51 |
Blood urea nitrogen (mg/dL) | ||||||||
Period 3—28 days | 8.43 | 8.43 | 8.30 | 8.20 | 0.22 | 0.63 | < 0.001 | 0.28 |
Period 29—56 days | 9.99 | 11.3 | 11.2 | 11.2 | 0.23 | 0.63 | < 0.001 | 0.32 |
Overall 3—56 days | 9.05 | 9.56 | 9.46 | 9.56 | 0.28 | 0.49 | < 0.001 | 0.42 |